Methotrexate-Induced Megaloblastic Anemia
Key Point
In patients on long-term methotrexate therapy, methotrexate-induced folate deficiency is the most common cause of megaloblastic anemia. Methotrexate inhibits dihydrofolate reductase, blocking the conversion of dihydrofolate to tetrahydrofolate, which is essential for DNA synthesis.
High-YieldNEET PG
Methotrexate is a folate antagonist used in:
Megaloblastic anemia is a well-recognized toxicity of long-term methotrexate use.
Mechanism of Methotrexate-Induced Megaloblastic Anemia
Loading diagram...
Comparison: Methotrexate vs. Other Causes in This Context
| Cause | Mechanism | Clinical Context | Reversibility |
|---|
| Methotrexate-induced folate deficiency | Inhibits dihydrofolate reductase | Long-term MTX therapy (RA, psoriasis) | Reversible with folinic acid (leucovorin) |
| Pernicious anemia | Autoimmune gastritis; anti-IF antibodies | Autoimmune disease (can coexist with RA) | Irreversible; requires B12 supplementation |
| Dietary folate deficiency | Inadequate intake | Malnutrition, alcoholism | Reversible with dietary supplementation |
| Nitrous oxide inhalation | Inactivates B12 cofactor | Substance abuse | Reversible if caught early |
Clinical Pearl
Methotrexate-induced megaloblastic anemia is preventable and reversible with folinic acid (leucovorin) supplementation. Patients on long-term methotrexate should receive concurrent folinic acid to prevent folate deficiency.
Mnemonic: MTX TOXICITY — Methotrexate → Teratogenic, Oral ulcers, Xerostomia, Immunosuppression, Cirrhosis, Infection, Thrombocytopenia, Yeast overgrowth (plus megaloblastic anemia)
Why Methotrexate Is the Most Common Cause in This Patient
- 1.
Clear temporal relationship: Patient has been on methotrexate for 10 years
- 2.
Mechanism is direct: Methotrexate directly inhibits folate metabolism
- 3.
Both B12 and folate are low: This pattern is consistent with methotrexate-induced folate deficiency (B12 may be secondarily low due to impaired absorption from intestinal damage)
- 4.
Reversibility: Folinic acid supplementation will correct the anemia, confirming methotrexate as the cause
Warning
Do not confuse methotrexate-induced folate deficiency with pernicious anemia. While both can coexist in RA patients (RA is an autoimmune disease), the primary cause here is methotrexate toxicity given the 10-year history of therapy.